The FDA's power to approve drugs faces sweeping challenge in lawsuit seeking to pull abortion pill from U.S. market

Mifepristone (Mifeprex) and Misoprostol, the two drugs used in a medication abortion, are seen at the Women’s Reproductive Clinic, which provides legal medication abortion services, in Santa Teresa, New Mexico, on June 17, 2022.

Robyn Beck | AFP | Getty Images

The Food and Drug Administration is squaring off with anti-abortion physicians in an unprecedented legal challenge to its more than two-decade-old approval of a pill used to terminate early pregnancies.

The Alliance for Hippocratic Medicine asked a federal district court in Dallas late last year to declare the FDA approval unlawful and completely remove the abortion pill from the U.S. market.

related investing news

Goldman Sachs upgrades Philip Morris, cites expansion in U.S. with smoke-free alternatives

The case has thrust the FDA in the middle of the fierce national battle over abortion access in the wake of the Supreme…

Read Story